ArticleMayo Clinic proceedings2018

Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors.

Cheng-Yi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.